New drug, WNTinib, delays tumor growth and improves survival in mouse models of children's liver cancer
A new drug called WNTinib can delay the growth of tumors and improve survival in hepatoblastoma, a type of liver cancer that occurs in...
Oct 25, 2024
Novel treatment strategy shows promise against common liver cancer in children
A team led by researchers at Baylor College of Medicine has been working on improving therapies for this devastating disease. They...
Feb 28, 2024
Collaborative study identifies potential targets to treat the most common childhood liver cancer
A collaborative study, led by Cima Universidad de Navarra, has identified key epigenetic targets for its treatment. This research opens ...
Oct 25, 2023
New research identifies a potential treatment target for hepatoblastoma in children
In a novel study appearing in The American Journal of Pathology, investigators studying a mouse model of hepatoblastoma report that the ...
Jan 24, 2023
New drug halves hearing loss in children following cancer treatment
Giving the drug sodium thiosulphate after chemotherapy reduces hearing loss in children treated for liver cancer, according to findings...
Jun 25, 2018